Protection of low density lipoprotein oxidation by the antioxidant agent IRFI005, a new synthetic hydrophilic vitamin E analogue

Free Radical Biology and Medicine

Volumn 26, Issue 7-8, 1999, Pages 858-868

  Iuliano, Luigi ^a   Pedersen, Jens Z ^c   Camastra, Caterina ^a   Bello, Valentina ^a   Ceccarelli, Stefano ^b   Violi, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Biomedica Foscama Research Center   (Italy)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Antioxidants; Atherosclerosis; Cardiovascular disease; Cholesterol; Free radicals; Lipid peroxidation; Lipoprotein

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOPHEROL DERIVATIVE; BENZOQUINONE; CAROTENOID; CHOLESTEROL; FREE RADICAL; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; RAXOFELAST; TROLOX C; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; ELECTRON SPIN RESONANCE; ELECTROPHORETIC MOBILITY; FLUORESCENCE; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; OXIDATION; PRIORITY JOURNAL;

ADULT; AGED; ANTIOXIDANTS; ASCORBIC ACID; BENZOFURANS; COPPER SULFATE; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMANS; HYDROGEN PEROXIDE; KINETICS; LINOLEIC ACID; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MIDDLE AGED; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP; VITAMIN E;

ANIMALIA;

EID: 0032949383     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(98)00271-8     Document Type: Article

References (49)

1. Goldstein J.L., Ho J.K., Basu S.K., Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA. 76:1979;333-337.
2. Steinberg D., Parthasarathy C., Carew T.E., Khoo J.C., Witzum J.L. Beyond cholesterol modifications of low density lipoproteins that increases its atherogenicity. N. Engl. J. Med. 320:1989;915-924.
3. Esterbauer H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 3:1992;341-390.
4. Quinn M.T., Parthasarathy S., Fong L.G., Steinberg D. Oxidatively modified low density lipoproteins a potential role in recruitment and retention of monocyte/macrophages during atherogenesis . Proc. Natl. Acad. Sci. USA. 84:1987;2995-2998.
5. Autio I., Jaakkola O., Solakivi T., Nikkari T. Oxidized low density lipoprotein is chemotactic for arterial smooth muscle cells in culture. FEBS Lett. 227:1990;247-249.
6. Haberland M.E., Fong D., Cheng L. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science. 241:1988;215-218.
7. Yla-Herttuala S., Palinski W., Rosenfeld M.E., Parthasarathy S., Carew T.E., Butler S., Witztum J.L., Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1989;1086-1095.
8. Palinski W., Rosenfeld M.E., Yla-Herttuala S., Gurtener G.C., Socher S.S., Butler S.W., Parthasarathy S., Carew T.E., Steinberg D., Witztum J.L. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA. 86:1989;372-1376.
9. Boyd H.C., Grown A.M., Wolfbauer G., Chait A. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from Watanabe heritable hyperlipidemic rabbits. Am. J. Pathol. 135:1989;815-825.
10. Praticò D., Iuliano L., Mauriello A., Spagnoli L., Lawson J.A., Maclouf J., Violi F., FitzGerald G.A. Localization of distinct F2-isoprostanes in human atherosclerotic lesions. J. Clin. Invest. 100:1997;2028-2034.
11. Salonen J.T., Ylä-Herttuala S., Yamamoto R., Butler S., Korpela H., Salonen R., Nyyssönen K., Palinski W., Witztum J.L. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet. 339:1992;883-887.
12. Regnstrom J., Nilsson J., Tornvall P., Landou C., Hamsten A. Susceptibility to low density lipoprotein oxidation and coronary atherosclerosis in man. Lancet. 339:1992;1183-1186.
13. Cominacini L., Garbin U., Pastorino A.M., Davoli A., Campagnola M., De Santis A., Pasini C., Faccini G.B., Trevisan T.M., Bertozzo L., Pasini F., Lo Cascio V. Predisposition of LDL oxidation in patients with and without angiographically established coronary artery disease. Atherosclerosis. 99:1993;63-70.
14. Dieber-Rotheneder M., Puhl H., Waeg G., Striegel G., Esterbauer H. Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J. Lipid. Res. 32:1991;1325-1332.
15. Jialal I., Grundy S.M. Effect of dietary supplementation with α-tocopherol on the oxidative modification of low density lipoprotein. J. Lipid. Res. 33:1992;899-906.
16. Reaven P.D., Khouw A., Beltz W.F., Parthasarathy S., Witztum J.L. Effect of dietary antioxidant combinations in humans. Arterioscler. Thromb. 3:1993;590-600.
17. Belcher J.D., Balla J., Jacobs D.R., Gross M., Jacob H., Vercellotti G.M. Vitamin E, LDL, and endothelium. Brief oral vitamin E supplementation prevents oxidized LDL-mediated vascular injury in vitro. Arterioscler. Thromb. 13:1993;1779-1789.
18. Stampfer M.J., Hennekens C.H., Manson J.E., Colditz G.A., Rosner B., Willet W.C. Vitamin E consumption and the risk of coronary disease in woman. N. Engl. J. Med. 328:1993;1444-14449.
19. Freyschuss A., Stiko-Rahm A., Swedenborg J., Henriksson P., Bjorkhem I., Berglund L., Nilsson J. Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits. J. Clin. Invest. 91:1993;1282-1288.
20. Sparrow C.P., Doebber T.W., Olszewski J., Wu M.S., Ventre J., Stevens K.A., Chao Y. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N′,N′-diphenyl-phenylenediamine. J. Clin. Invest. 89:1992;1885-1891.
21. Kuzuya M., Kuzuya F. Probucol as antioxidant and antiatherogenic drug. Free Rad. Biol. Med. 14:1993;66-77.
22. Iuliano L., Praticò D., Ghiselli A., Bonavita M.S., Violi F. Reaction of dipyridamole with the hydroxyl radical. Lipids. 27:1992;349-353.
23. Iuliano L., Pedersen J.Z., Rotilio G., Ferro D., Violi F. A potent chain breaking activity of the cardiovascular drug dipyridamole. Free Rad. Biol. Med. 18:1995;239-247.
24. Iuliano L., Colavita A.R., Camastra C., Bello V., Quintarelli C., Alessandroni M., Piovella F., Violi F. Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole. Br. J. Pharmacol. 119:1996;1438-1446.
25. Stephens N.G., Parson A., Schofield P.M., Kelly F., Cheeseman K., Mitchinson K.A. Randomised controlled trial of vitamin E in patients with coronary disease Cambridge Heart Antioxidant Study (CHAOS) . Lancet. 347:1996;781-786.
26. Rapola J.M., Virtamo J., Ripatti S., Huttenen J.K., Albanes D., Taylor P.R. Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet. 349:1997;1715-1720.
27. Doelman C.J., Bast A. Oxygen radicals in lung pathology. Free Radic. Biol. Med. 9:1990;381-400.
28. Buckley M.T., Goa K.L., Price A.H., Brogden R.H. Probucol a reappraisal of its pharmacological properties and therapeutic use in hypercholesterolemia . Drugs. 37:1989;761-800.
29. Walldius G.U., Erikson U., Olsson A.G., Bergstrand L., Haddel K., Johansson J., Kaijser L., Lassvik C., Molgaard J., Nilsson S. The effect of probucol on low femoral atherosclerosis the Probucol Quantitative Regression Swedish Trial (PQRST) . Am. J. Cardiol. 74:1994;875-883.
30. Zhang S.H., Reddick R.L., Avdievich E., Kester Surles L., Jones R.G., Reynolds J.B., Quarfordt S.H., Maeda N. Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E deficient mice. J. Clin. Invest. 99:1997;2858-2866.
31. Campo G.M., Ceccarelli S., Squadrito F., Altavilla D., Dorigotti L., Caputi A.P. Raxofelast (IRFI016) a new hydrophilic vitamin E-like antioxidant agent . Cardiovasc. Drug Rev. 15:1997;157-173.
32. Ceccarelli S., De Vellis P., Scuri R., Zanarella S. Synthesis of novel 2-substituted-5-oxo-curamarans via a direct route to 2,3-dihydro-5-hydroxy-2-benzofuranacetic acids. J. Heterocycl. Chem. 30:1993;679-690.
33. Noguchi N., Yamashita H., Gotoh N., Yamamoto Y., Numano R., Niki E. 2,2′-Azobis(4-methoxy-2,4-dimethylvaleronitrile), a new lipid-soluble azo initiator: application to oxidation of lipids and low-density lipoprotein in solution and in aqueous dispersions. Free Radic. Biol. Med. 24:1998;259-268.
34. Nourooz-Zadeh J., Tajaddini-Sarmadi J., Wolff S.P. Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal. Biochem. 220:1994;403-409.
35. Hatch F.T., Lees R.S. Practical methods for plasma lipoprotein analysis. Adv. Lipid Res. 6:1968;1-68.
36. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klent D.J. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:1985;76-85.
37. Stacewicz-Sapuntzakis M., Bowen P.E., Kikendall J.W., Burgess M. Simultaneous determination of retinol and various carotenoids their distribution in middle-aged men and women . J. Micronutr. Anal. 3:1987;27-45.
38. Iuliano L., Signore A., Vallabjosula S., Colavita A.R., Camastra C., Ronga C., Sbarigia E., Fiorani F., Violi F. Preparation and biodistribution of 99mTechnetium labeled oxidized LDL in man. Atherosclerosis. 126:1996;131-141.
39. Jialal I., Grundy S.M. Preservation of the endogenous antioxidants in low density lipoprotein by ascorbic acid but not by probucol during oxidative modification. J. Clin. Invest. 87:1991;597-601.
40. Bowry V.W., Stocker R. Tocopherol-mediated peroxidation. The pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low density lipoprotein. J. Am. Chem. Soc. 115:1993;6029-6044.
41. Yoshida Y., Tsuchiya J., Niki E. Interaction of α-tocopherol with copper and its effect on lipid peroxidation. Biochim. Biophis. Acta. 1200:1994;85-92.
42. Iuliano L., Pedersen J.Z., Ghiselli A., Praticò D., Rotilio G., Violi F. Mechanism of reaction of a suggested superoxide dismutase mimic, Fe(II)-N,N,N′,N′-tetrakis(2-pyridylmethyl)ethylenediamine. Arch. Biochem. Biophys. 293:1992;153-157.
43. Burton G.W., Doba T., Gobe E.J., Hughes L., Lee F.L., Prasad L., Ingold K.U. Autoxidation of biological molecules. 4. Maximizing the antioxidant activity of phenols. J. Am. Chem. Soc. 107:1985;7053-7065.
44. Ingold K.U., Burton G.W., Foster D.O., Zuker M., Hughes L., Lacelle S., Lusztyk E., Slaby M. A new vitamin E analogue more active than α-tocopherol in the rat curative miophaty bioassay. FEBS Lett. 205:1986;117-120.
45. Niki E., Saito T., Kawakami A., Kamiya Y. Inhibition of oxidation of methyl linoleate in solution by vitamin E and vitamin C. J. Biol. Chem. 259:1984;4177-4182.
46. Packer J.E., Slater T.F., Willson R. Direct observation of free radical interaction between vitamin E and vitamin C. Nature. 278:1979;737-738.
47. Fessenden R.W., Hitachi A., Nagarayanan V. Measurement of the dipole moment of a peroxyl radical by microwave dielectric absorption. J. Phys. Chem. 88:1984;107-110.
48. Boyd S.L., Boyd R.J., Barclay L.R.C. A theoretical investigation of the structures and properties of peroxyl radicals. J. Am. Chem. Soc. 112:1990;5724-5730.
49. Ross L., Barclay C., Vinqvist M.R. Membrane peroxidation inhibiting effects of water-soluble antioxidants on phospholipids of different charge types . Free Radic. Biol. Med. 16:1994;779-788.